Skip to content
OpenCapital
Get started

Zentalis Pharmaceuticals, Inc. ZNTL Q4 2024 Annual earnings

Reported March 26, 2025 · Before market open

Revenue$26.9M
EPS-$0.66Beat by $0.09
EPS estimate-$0.75

Next report

Aug 5, 2026 (In 1 week)
EPS estimate-$0.45

Versus estimates

Revenue

Q4 2024$26.9M

Diluted EPS

Q1 2026-$0.50Miss by $0.01Q4 2025-$0.49Miss by $0.08Q3 2025-$0.37Beat by $0.12Q2 2025-$0.37Beat by $0.19Q1 2025-$0.67In line
Q4 2024-$0.66Beat by $0.09

Ask the moment Zentalis Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Zentalis Pharmaceuticals, Inc. report Q4 2024 earnings?
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Q4 2024 earnings on March 26, 2025 before market open.
What were Zentalis Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?
Zentalis Pharmaceuticals, Inc. reported revenue of $26.9M and eps of $-0.66 for Q4 2024.
Did Zentalis Pharmaceuticals, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.75 by $0.09.
Where can I find Zentalis Pharmaceuticals, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001725160-25-000067) directly on SEC EDGAR. The filing index links above go to sec.gov.